7: e358-e366
Most patients with obesity have health behaviors that reduce the likelihood of Mounjaro being effective
Similar content being viewed by others Introduction Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have revolutionized the treatment landscape for type 2 diabetes mellitus (T2DM) and obesity, offering significant benefits in glycemic control, weight reduction, and cardiometabolic protection
dexpanthenolDexpanthenol is a topical emollient applied on the skin to relieve itching from eczema and other skin disorders, and promote the healing of skin lesions
High dose ( 0.5 mg/kg/d) or long-term use may lead to hypoglycemia, especially in patients with diabetes or insulin resistance
The pathological features of OA include cartilage degeneration, synovial inflammation, subchondral bone remodeling, and joint space narrowing, among others (Zhou et al., 2024)